AXIS Capital Holdings Limited entered into a stock repurchase agreement to buy 2,404,133 common shares from T-VIII PubOpps LP for an aggregate price of approximately $238 million. The seller is an investment vehicle managed by Stone Point Capital, whose Trident Funds held about 3.1% of AXIS’s outstanding common shares, a position that will be reduced to zero after this transaction.
The repurchase is being made under AXIS’s existing Board-authorized $400 million share repurchase program, meaning it uses part of an already approved capital return plan. The filing also notes that director Charles Davis has leadership roles at Stone Point and the Trident Funds, highlighting that this is a sizable, negotiated block repurchase involving a shareholder affiliated with a board member.
AXIS Capital Holdings (AXS) appointed A. Tom Bolovinos as Chief Accounting Officer and Principal Accounting Officer, effective December 2, 2025. He joins from Kemper Corporation, where he was Senior Vice President – Corporate Controller, and previously held leadership roles at Assurant, General Reinsurance, and The Navigators Group.
Compensation includes an annual base salary of $380,000 and eligibility for a non‑equity incentive with a target equal to 65% of base salary. He will receive a $360,000 cash award within his first month, subject to forfeiture if he resigns for any reason or is terminated for cause within his first year. Equity elements include a sign‑on RSU grant with a grant date fair value of $230,000 vesting pro rata over three years, plus eligibility under the 2017 Long Term Equity Compensation Plan with an annual target equity award valued at $290,000. The company disclosed no related‑party relationships or arrangements tied to this appointment.
AXIS Capital Holdings Limited (NYSE: AXS) filed an automatic shelf registration (Form S-3 ASR) that allows the company to offer, from time to time after effectiveness, common shares, preference shares, depositary shares, debt securities, warrants, purchase contracts and purchase units. Its finance subsidiaries, AXIS Specialty Finance LLC and AXIS Specialty Finance PLC, may also issue debt securities fully and unconditionally guaranteed by AXIS Capital.
Unless a prospectus supplement states otherwise, net proceeds will be used for general corporate purposes. AXS common shares trade on the NYSE under “AXS.” As context, authorized share capital is 800,000,000 shares, and shares outstanding were 77,037,743 as of September 30, 2025.
AXIS Capital Holdings Limited furnished investor presentation materials via an 8-K. The company submitted slides for upcoming investor meetings as Exhibit 99.1, and made the presentation available on its investor website at www.investor.axiscapital.com.
The materials were provided on November 3, 2025 and are designated as “furnished,” not “filed,” under the Exchange Act. The filing also lists the company’s exchange‑traded securities: common shares under AXS and depositary shares representing a 1/100th interest in 5.50% Series E preferred shares under AXS PRE.
Axis Capital Holdings Ltd filed a Form 13F reporting institutional holdings with a total value of $263,900,140 across 2 reported positions. The report is signed by Peter Vogt, Chief Financial Officer and is dated 10-29-2025.
AXIS Capital (AXS) reported Q3 2025 results showing stronger underwriting and higher profitability. Net income was $301.9M versus $180.7M a year ago, and earnings per diluted share were $3.74 versus $2.04. Total revenues were $1.67B (from $1.61B).
Net premiums earned rose to $1.45B (from $1.37B). Underwriting income improved to $188.3M (from $135.2M) as the combined ratio fell to 89.4% (from 93.1%). Net investment income was $184.9M (vs. $205.1M), while net investment gains were $30.9M (vs. $32.2M). The quarter included foreign exchange gains of $13.5M.
Year to date, net income was $719.3M and the combined ratio was 89.5%. Operating cash flow for the first nine months was a use of $671.3M. Shareholders’ equity ended the quarter at $6.37B, aided by an AOCI swing to $10.2M. Common shares outstanding were 77,037,743 as of October 24, 2025.
AXIS Capital Holdings Limited furnished an 8-K announcing its third quarter 2025 results via a press release and an investor financial supplement, attached as Exhibit 99.1 and Exhibit 99.2.
The company stated these materials are furnished and not deemed “filed” under Section 18 of the Exchange Act. AXIS’s common shares trade on the NYSE under AXS, and depositary shares representing a 1/100th interest in its 5.50% Series E preferred shares trade as AXS PRE.
Henry B. Smith, a director of Axis Capital Holdings Ltd (AXS), reported a sale of common shares. On 08/21/2025 Mr. Smith sold 3,500 shares of AXS at a weighted average price of $98.67, with transaction prices in the range $98.47 to $98.83. Following the sale he beneficially owns 47,295 shares, held directly. The Form 4 was signed by G. Christina Gray-Trefry, Attorney-in-Fact, on 08/25/2025. The filer offers to provide a breakdown of shares sold at each separate price within the disclosed range upon request.
Daniel J. Draper, Group Chief Underwriting Officer and director of Axis Capital Holdings Ltd (AXS), reported the sale of 4,305 common shares on 08/20/2025 at a weighted-average price of $97.57 per share (trades ranged $97.22–$97.88). After the sale he beneficially owns 16,269 shares. The filing was signed by an attorney-in-fact on 08/21/2025. The report discloses the sale price range and notes Mr. Draper will provide details of shares sold at each price upon request.
Form 144 notice for proposed sale of securities by a holder of Axis Capital Holders Limited (AXS). The filing shows an intended sale of 3,500 common shares through Morgan Stanley Smith Barney LLC on 08/21/2025 with an aggregate market value of $345,338.35. The issuer olumns list 78,173,983 shares outstanding. The securities being sold were originally acquired as restricted stock vesting under a registered plan on 01/14/2011 (2,833 shares) and 01/30/2012 (667 shares), paid in cash at vesting. No sales by the same person are reported in the prior three months. The filer affirms they are not aware of undisclosed material adverse information about the issuer.